Clarifi Imaging System is a noninvasive, noncontact, and non-ionizing testing for the microvascular assessment. It does not expose the patient to any harmful radiation. It is very easy to do and generates images in seconds. This system provides information about the delivery and extraction of oxygen to the tissues, which helps providers identify patients that are at risk for vascular complications. It also helps identify specific areas of compromised circulation before actual presence of ulcerations or other visible symptoms.
Clarifi imaging System gives a complete picture of the tissue health (tissue oxygenation and perfusion data) by mapping and quantifying 5 key microvascular biomarkers listed below as follows:
StO2 is the tissue hemoblogin oxygen saturation
HbO2 is the oxy-hemoglobin
HbR is the deoxy-hemoglobin
HbT1 is the superficial (papillary dermis) hemoglobin
HbT2 is the deep (reticular dermis) hemoglobin
Oxygenation markers are StO2, HbO2, HbR and perfusion markers are HbT1, HbT2. Clarify system provides a color coded map of each of these 5 biomarkers.
It is important to note that traditional noninvasive circulatory tests, such as arterial doppler, ABI, TBI, provide information about the macrovascular status of the large blood vessels. Clarifi Imaging system provides information about the microvascular status of the small blood vessels. Evaluating microvascular status is extremely important especially in conditions such as arteriovenous shunting in which the blood does not get into the capillary beds.
To get a more complete picture of a patient’s peripheral vascular health it is essential to asses both macrovascular and microvascular systems. By doing so helps clinicians identify at risk patients before any visible signs of ulceration.
To find out more about this system please click here.